筛选条件 共查询到108条结果
排序方式
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis

期刊: CLINICAL LUNG CANCER, 2021; 22 (4)

Real-world surgical prognoses of synchronous multiple primary lung cancer (SMPLC) are still uncertain. This study systematically assessed the long-ter......

Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers

期刊: CLINICAL LUNG CANCER, 2021; 22 (4)

This study aimed to validate the prognostic value of the presence of solid components in the mediastinal window in clinical stage I pulmonary subsolid......

Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis

期刊: CLINICAL LUNG CANCER, 2021; 22 (4)

We aimed to identify the optimal number of examined lymph nodes (ELNs) in sublobar resection (SLR) and assess the survival differences between SLR wit......

Extended Sleeve Lobectomy is an Alternative for Centrally Located Lung Cancer With Superior Short- and Long-term Outcomes

期刊: CLINICAL LUNG CANCER, 2021; 22 (4)

The survival benefit of extended sleeve lobectomy (ESL) is unclear, and preoperative selection remains controversial. Twenty-three patients underwent ......

Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line

期刊: CLINICAL LUNG CANCER, 2021; 22 (2)

We studied the effect of any steroid use in patients with advanced non-small-cell lung cancer receiving immunotherapy with first-line pembrolizumab, a......

Concurrent Apatinib and Brain Radiotherapy in Patients With Brain Metastases From Driver Mutation-negative Non small-cell Lung Cancer: Study Protocol for an Open-label Randomized Controlled Trial

期刊: CLINICAL LUNG CANCER, 2021; 22 (2)

Brain radiotherapy (BR) is a well-recognized approach for multiple brain metastases (BMs) from non small-cell lung cancer (NSCLC). However, the progno......

Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial

期刊: CLINICAL LUNG CANCER, 2021; 22 (2)

We investigated the potential use of mutant TP53 in prediction and prognosis of patients with non-small cell lung cancer. We analyzed data obtained fr......

Bronchial Arterial Infusion Chemotherapy Plus Drug-eluting Bead Chemoembolization for Recurrence of Carina Region-induced Severe Right Main Bronchial Stenosis After Pneumonectomy

期刊: CLINICAL LUNG CANCER, 2021; 22 (3)

Recurrence of lung cancer in the carina region-induced severe right main bronchial stenosis after pneumonectomy is a challenging clinical problem. Des......

Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller

期刊: CLINICAL LUNG CANCER, 2021; 22 (2)

The optimal resection for patients with clinical stage I ground-glass opacity (GGO) lung adenocarcinomas with maximum diameters ? 2 cm remains controv......

A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)

期刊: CLINICAL LUNG CANCER, 2021; 22 (2)

Background: Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is now a standard treatment of previous......

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

期刊: CLINICAL LUNG CANCER, 2021; 22 (3)

This study aimed to compare the efficacy and safety of simultaneous EGFR tyrosine kinase inhibitor (TKI) and chemotherapy with that of sequential trea......

共108条页码: 1/8页15条/页